<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Beyond the Science: Advancing the “Art and Craft” of Implementation in the Training and Practice of Global Health</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>252</FirstPage>
			<LastPage>256</LastPage>
			<ELocationID EIdType="pii">3857</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.131</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Ejemai Amaize</FirstName>
					<LastName>Eboreime</LastName>

						<AffiliationInfo>
						<Affiliation>Department of Medicine, Faculty of Medicine and Dentistry, University of
Alberta, Edmonton, AB, Canada</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Department of Planning, Research and
Statistics, National Primary Health Care Development Agency, Abuja, Nigeria</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0001-8277-2570</Identifier>

</Author>
<Author>
					<FirstName>Aduragbemi</FirstName>
					<LastName>Banke-Thomas</LastName>
<Affiliation>Department of Health Policy, London School of Economics and Political
Science, London, UK</Affiliation>
<Identifier Source="ORCID">0000-0002-4449-0131</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>04</Month>
					<Day>25</Day>
				</PubDate>
			</History>
		<Abstract>Interesting debates are ongoing on how to develop practical implementation science competencies that can bridge the “know-do” gap in global health. We advance these debates by arguing that apprenticeship and mentorship models drawn from “art and craft” used in industry is the missing piece of the puzzle that will bridge the persisting gap between academics and real-world practitioners. We propose examples of such models and how they can be applied to improve existing capacity building programs, as well as implementation in practice.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Implementation Science</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Global Health</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Mentorship</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Apprenticeship</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Training</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Capacity Building</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3857_f269cb7796c3319c9aa4d146b52139e6.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The Long and Winding Road: A Systematic Literature Review Conceptualising Pathways for Hypertension Care and Control in Low- and Middle-Income Countries</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>257</FirstPage>
			<LastPage>268</LastPage>
			<ELocationID EIdType="pii">3862</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.105</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Rachel</FirstName>
					<LastName>Brathwaite</LastName>
<Affiliation>Brown School, Washington University in St Louis, St Louis, MO, USA</Affiliation>
<Identifier Source="ORCID">0000-0002-9363-3581</Identifier>

</Author>
<Author>
					<FirstName>Eleanor</FirstName>
					<LastName>Hutchinson</LastName>
<Affiliation>Department of Global Health and Development, Faculty of Public Health
and Policy, London School of Hygiene and Tropical Medicine, London, UK</Affiliation>
<Identifier Source="ORCID">0000-0002-9718-2407</Identifier>

</Author>
<Author>
					<FirstName>Martin</FirstName>
					<LastName>McKee</LastName>
<Affiliation>Department of Health Services Research and Policy, Faculty of Public Health
and Policy, London School of Hygiene and Tropical Medicine, London, UK</Affiliation>
<Identifier Source="ORCID">0000-0002-0121-9683</Identifier>

</Author>
<Author>
					<FirstName>Benjamin</FirstName>
					<LastName>Palafox</LastName>
<Affiliation>Department of Health Services Research and Policy, Faculty of Public Health
and Policy, London School of Hygiene and Tropical Medicine, London, UK</Affiliation>
<Identifier Source="ORCID">0000-0003-3775-4415</Identifier>

</Author>
<Author>
					<FirstName>Dina</FirstName>
					<LastName>Balabanova</LastName>
<Affiliation>Department of Global Health and Development, Faculty of Public Health
and Policy, London School of Hygiene and Tropical Medicine, London, UK</Affiliation>
<Identifier Source="ORCID">0000-0001-7163-3428</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>11</Month>
					<Day>25</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span class=&quot;fontstyle0&quot;&gt;Background&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;Hypertension control is poor everywhere, especially in low- and middle-income countries (LMICs). An effective response requires understanding factors acting at each stage on the patients’ pathway through the health system from entry or first contact with the health system, through to treatment initiation and follow up. This systematic review aimed to identify barriers to and facilitators of hypertension control along this pathway and, respectively, ways to overcome or strengthen them.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Methods&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;MEDLINE, EMBASE, Global Health, CINAHL Plus, and Africa-Wide Information (1980-April 2019) were searched for studies of hypertensive adults in LMICs reporting details of at least 2 adequately described health system contacts. Data were extracted and analysed by 2 reviewers. Themes were developed using NVivo in patient-related (sociodemographic, knowledge and health beliefs, health status and co-morbidities, trade-offs), social (social relationships and traditions) and health system domains (resources and processes). Results are reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Results&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;From 2584 identified records, 30 were included in the narrative synthesis. At entry, ‘health systems resources and processes’ and ‘knowledge and beliefs about hypertension’ dominated while ‘social relations and traditions’ and ‘comorbidities’ assume greater importance subsequently, with patients making ‘trade-offs’ with family priorities during follow up. Socio-demographic factors play a role, but to a lesser extent than other factors. Context matters.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Conclusion&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;Understanding the changing barriers to hypertension control along the patient journey is necessary to develop a comprehensive and efficient response to this persisting problem.&lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Systematic Review</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hypertension Control</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Healthcare Delivery</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Health Systems</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Pathways to Care</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3862_533fa796b43291fc61a9e812a50c3fb6.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Engaging Knowledge Users with Mental Health Experience in a Mixed-Methods Systematic Review of Post-secondary Students with Psychosis: Reflections and Lessons Learned from a Master’s Thesis</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>269</FirstPage>
			<LastPage>276</LastPage>
			<ELocationID EIdType="pii">3877</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.138</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Victoria</FirstName>
					<LastName>Sanderson</LastName>
<Affiliation>School of Nursing, Faculty of Health Sciences, University of Ottawa, Ottawa,
ON, Canada</Affiliation>
<Identifier Source="ORCID">0000-0003-1310-3052</Identifier>

</Author>
<Author>
					<FirstName>Amanda</FirstName>
					<LastName>Vandyk</LastName>
<Affiliation>School of Nursing, Faculty of Health Sciences, University of Ottawa, Ottawa,
ON, Canada</Affiliation>
<Identifier Source="ORCID">0000-0002-2356-7136</Identifier>

</Author>
<Author>
					<FirstName>Jean Daniel</FirstName>
					<LastName>Jacob</LastName>
<Affiliation>School of Nursing, Faculty of Health Sciences, University of Ottawa, Ottawa,
ON, Canada</Affiliation>
<Identifier Source="ORCID">0000-0002-4032-2229</Identifier>

</Author>
<Author>
					<FirstName>Ian D.</FirstName>
					<LastName>Graham</LastName>
<Affiliation>School of Epidemiology and Public Health, University of Ottawa,
Ottawa, ON, Canada</Affiliation>
<Identifier Source="ORCID">0000-0002-3669-1216</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>01</Month>
					<Day>28</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span class=&quot;fontstyle0&quot;&gt;Engaging knowledge users (KUs) as research team members throughout the research process helps generate relevant knowledge and may improve uptake of research results. The purpose of this article is to describe how an integrated knowledge translation (iKT) approach was embedded within a master’s thesis project comprising a mixed-methods systematic review. KUs were engaged in four distinct phases of the systematic review process, including (1) proposal development; (2) development of the research question and approach; (3) creation of an advisory panel; and (4) an end of study meeting to interpret findings and plan dissemination of findings. The extent of each KU’s engagement on the research team fluctuated during the study. Challenges included maintaining the same KUs throughout the project and maintaining the scope of the project to align with a master’s thesis. Our suggestions for optimizing graduate student iKT projects include having regular team meetings and periodically checking in with team members to encourage reflection on overall engagement and progress of the project. Overall, KUs helped create a research project designed to address their needs and provided input on how results might translate into implications for clinical practice, education, academic policy, and future research within their respective contexts.&lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Integrated Knowledge Translation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Systematic Review</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Knowledge User</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Psychosis</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3877_8d9a6e908ed2b731fb96151d9bb94d49.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Medical Service Utilization and Direct Medical Cost of Stroke in Urban China</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>277</FirstPage>
			<LastPage>286</LastPage>
			<ELocationID EIdType="pii">3865</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.111</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Dawei</FirstName>
					<LastName>Zhu</LastName>
<Affiliation>China Center for Health Development Studies, Peking University, Beijing,
China</Affiliation>
<Identifier Source="ORCID">0000-0003-0167-6603</Identifier>

</Author>
<Author>
					<FirstName>Shi</FirstName>
					<LastName>Xuefeng</LastName>

						<AffiliationInfo>
						<Affiliation>School of Management, Beijing University of Chinese Medicine,
Beijing, China</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>National Institute of Chinese Medicine Development and
Strategy, Beijing University of Chinese Medicine, Beijing, China</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0001-7056-2912</Identifier>

</Author>
<Author>
					<FirstName>Stephen</FirstName>
					<LastName>Nicholas</LastName>

						<AffiliationInfo>
						<Affiliation>School of
Economics and School of Management, Tianjin Normal University, Tianjin,
China</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Australian National Institute of Management and Commerce, Sydney,
NSW, Australia</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Research Institute for International Strategies, Guangdong
University of Foreign Studies, Guangzhou, China</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Newcastle Business School,
University of Newcastle, Newcastle, NSW, Australia</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0001-6770-7105</Identifier>

</Author>
<Author>
					<FirstName>Siyuan</FirstName>
					<LastName>Chen</LastName>

						<AffiliationInfo>
						<Affiliation>School of Public Health,
Peking University, Beijing, China</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>China Center for Health Development Studies, Peking University, Beijing,
China</Affiliation>
						</AffiliationInfo>

</Author>
<Author>
					<FirstName>Ruoxi</FirstName>
					<LastName>Ding</LastName>
<Affiliation>Institute of Population Research, Peking
University, Beijing, China</Affiliation>

</Author>
<Author>
					<FirstName>Lieyu</FirstName>
					<LastName>Huang</LastName>

						<AffiliationInfo>
						<Affiliation>School of Management, Beijing University of Chinese Medicine,
Beijing, China</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>National Institute of Chinese Medicine Development and
Strategy, Beijing University of Chinese Medicine, Beijing, China</Affiliation>
						</AffiliationInfo>

</Author>
<Author>
					<FirstName>Yong</FirstName>
					<LastName>Ma</LastName>
<Affiliation>China Health Insurance Research Association,
Beijing, China</Affiliation>

</Author>
<Author>
					<FirstName>Ping</FirstName>
					<LastName>He</LastName>
<Affiliation>China Center for Health Development Studies, Peking University, Beijing,
China</Affiliation>
<Identifier Source="ORCID">0000-0001-5040-5012</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>12</Month>
					<Day>24</Day>
				</PubDate>
			</History>
		<Abstract>Background&lt;br /&gt;Understanding the treatment costs of stroke can guide health policies and interventions. However, few studies have analyzed the treatment costs of stroke in China. The aim of this study is to assess stroke-related medical service utilization, direct costs of stroke and associated stroke predictors, and, second, to understand the structure of medical resource use.&lt;br /&gt; &lt;br /&gt;Methods&lt;br /&gt;This study used a 5% random sample of claim data from China’s Urban Basic Medical Insurance between January 2013 to December 2016. The sampling design assigned a sample weight to each beneficiary. Weighted descriptive analyses, Poisson regression and generalized linear model were used to analyze the medical service utilization, costs and their associations with patient characteristics.&lt;br /&gt; &lt;br /&gt;Results&lt;br /&gt;In urban China, the annual prevalence of stroke was 730.43 (95% CI = 730.10-730.76) cases per 100 000 people, and nearly 2% of total health expenditures of urban residents was spent on stroke-related medical costs. Weighted average annual total medical cost of stroke was RMB10 637 [95% CI = 10 435-10 840] (US$1682, 95% CI = 1650-1714), with annual out-of-pocket (OOP) cost of RMB3093 [95% CI = 3026-3161] (US$489, 95% CI = 478-500). The average yearly number of stroke-related outpatient visit was 1.67 [SD = 3.39] and inpatient admission was 0.79 [SD = 0.83], with an average cost of RMB440 [SD = 739] (US$70, SD = 117) for outpatients and RMB12 702 [SD = 21 424] (US$2008, SD = 3387) for inpatients. Inpatient costs accounted for 94% (RMB10 034 or US$ 1586) of medical costs, and tertiary hospitals were the main provider of stroke care. Stroke-related medical care utilization and direct costs were associated with gender, age, pathological stroke types and insurance status. Medication costs contributed to 50.6% (RMB5382 or US$ 851) of the average stroke-related medical costs.&lt;br /&gt; &lt;br /&gt;Conclusion&lt;br /&gt;China’s health system bares a large economic burden from stroke. Specific policies are needed to strengthen the capacity of secondary hospitals, alter the structure of medical resource allocation, and target specific sections of the stroke population.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Stroke</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Medical Service Utilization</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Direct Medical Cost</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Urban China</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cost of Illness</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Treatment Cost</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3865_866d90e0921ac7b024b47d672445a086.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Access of Migrant Youths in Sweden to Sexual and Reproductive Healthcare: A Cross-sectional Survey</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>287</FirstPage>
			<LastPage>298</LastPage>
			<ELocationID EIdType="pii">3868</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.123</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mazen</FirstName>
					<LastName>Baroudi</LastName>
<Affiliation>Department of Epidemiology and Global Health, Umeå University, Umeå,
Sweden</Affiliation>
<Identifier Source="ORCID">0000-0002-0609-8745</Identifier>

</Author>
<Author>
					<FirstName>Faustine</FirstName>
					<LastName>Nkulu-Kalengayi</LastName>
<Affiliation>Department of Epidemiology and Global Health, Umeå University, Umeå,
Sweden</Affiliation>

</Author>
<Author>
					<FirstName>Isabel</FirstName>
					<LastName>Goicolea</LastName>
<Affiliation>Department of Epidemiology and Global Health, Umeå University, Umeå,
Sweden</Affiliation>

</Author>
<Author>
					<FirstName>Robert</FirstName>
					<LastName>Jonzon</LastName>

						<AffiliationInfo>
						<Affiliation>The Public Health Agency of Sweden, Solna, Sweden</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Department of Epidemiology and Global Health, Umeå University, Umeå,
Sweden</Affiliation>
						</AffiliationInfo>

</Author>
<Author>
					<FirstName>Miguel</FirstName>
					<LastName>San Sebastian</LastName>
<Affiliation>Department of Epidemiology and Global Health, Umeå University, Umeå,
Sweden</Affiliation>
<Identifier Source="ORCID">0000-0001-7234-3510</Identifier>

</Author>
<Author>
					<FirstName>Anna-Karin</FirstName>
					<LastName>Hurtig</LastName>
<Affiliation>Department of Epidemiology and Global Health, Umeå University, Umeå,
Sweden</Affiliation>
<Identifier Source="ORCID">0000-0001-7087-1467</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>12</Month>
					<Day>05</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span class=&quot;fontstyle0&quot;&gt;Background&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;This study aims to assess migrant youths’ access to sexual and reproductive healthcare (SRHC) in Sweden, to examine the socioeconomic differences in their access, and to explore the reasons behind not seeking SRHC.&lt;/span&gt;&lt;br /&gt; &lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Methods&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;A cross-sectional survey was conducted for 1739 migrant youths 16 to 29 years-old during 2018. The survey was self-administered through: ordinary post, web survey and visits to schools and other venues. We measured access as a 4-stage process including: healthcare needs, perception of needs, utilisation of services and met needs.&lt;/span&gt;&lt;br /&gt; &lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Results&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;Migrant youths faced difficulties in accessing SRHC services. Around 30% of the participants needed SRHC last year, but only one-third of them fulfilled their needs. Men and women had the same need (27.4% of men [95% CI: 24.2, 30.7] vs. 32.7% of women [95% CI: 28.2, 37.1]), but men faced more difficulties in access. Those who did not categorise themselves as men or women (50.9% [95% CI: 34.0, 67.9]), born in South Asia (SA) (39% [95% CI: 31.7, 46.4]), were waiting for residence permit (45.1% [95% CI: 36.2, 54.0]) or experienced economic stress (34.5% [95% CI: 30.7, 38.3]) had a greater need and found more difficulties in access. The main difficulties were in the step between the perception of needs and utilisation of services. The most commonly reported reasons for refraining from seeking SRHC were the lack of knowledge about the Swedish health system and available SRHC services (23%), long waiting times (7.8%), language difficulties (7.4%) and unable to afford the costs (6.4%).&lt;/span&gt;&lt;br /&gt; &lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Conclusion&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;There is an urgent need to improve migrant youths’ access to SRHC in Sweden. Interventions could include: increasing migrant youths’ knowledge about their rights and the available SRHC services; improving the acceptability and cultural responsiveness of available services, especially youth clinics; and improving the quality of language assistance services.&lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Migrants</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Youth</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Access to Healthcare</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Sexual Health</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Reproductive Health</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Sweden</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3868_70162fe655ec381ac6312ebf026aac54.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Understanding the Costs of Surgery: A Bottom-Up Cost Analysis of Both a Hybrid Operating Room and Conventional Operating Room</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>299</FirstPage>
			<LastPage>307</LastPage>
			<ELocationID EIdType="pii">3870</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.119</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Sejal</FirstName>
					<LastName>Patel</LastName>
<Affiliation>Department of Operating Rooms, Radboud Institute for Health Sciences,
Radboud University Medical Center, Nijmegen, The Netherlands</Affiliation>
<Identifier Source="ORCID">0000-0002-5858-5166</Identifier>

</Author>
<Author>
					<FirstName>Melanie</FirstName>
					<LastName>Lindenberg</LastName>

						<AffiliationInfo>
						<Affiliation>Division of
Psychosocial Research and Epidemiology, The Netherlands Cancer InstituteAntoni van Leeuwenhoek, Amsterdam, The Netherlands</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Department of Health
Technology and Services Research, University of Twente, Enschede, The
Netherlands</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0001-7522-1009</Identifier>

</Author>
<Author>
					<FirstName>Maroeska M.</FirstName>
					<LastName>Rovers</LastName>

						<AffiliationInfo>
						<Affiliation>Department of Operating Rooms, Radboud Institute for Health Sciences,
Radboud University Medical Center, Nijmegen, The Netherlands</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Department for Health Evidence, Radboud Institute for Health
Sciences, Radboud University Medical Center, Nijmegen, The Netherlands</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0002-3095-170X</Identifier>

</Author>
<Author>
					<FirstName>Wim H.</FirstName>
					<LastName>Van Harten</LastName>

						<AffiliationInfo>
						<Affiliation>Division of
Psychosocial Research and Epidemiology, The Netherlands Cancer InstituteAntoni van Leeuwenhoek, Amsterdam, The Netherlands</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Department of Health
Technology and Services Research, University of Twente, Enschede, The
Netherlands</Affiliation>
						</AffiliationInfo>

</Author>
<Author>
					<FirstName>Theo J.M.</FirstName>
					<LastName>Ruers</LastName>
<Affiliation>Department of Surgery, The Netherlands Cancer Institute-Antoni van
Leeuwenhoek Hospital, Amsterdam, The Netherlands</Affiliation>

</Author>
<Author>
					<FirstName>Lieke</FirstName>
					<LastName>Poot</LastName>
<Affiliation>Department of Medical
Technology, Isala Hospital, Zwolle, The Netherlands</Affiliation>

</Author>
<Author>
					<FirstName>Valesca P.</FirstName>
					<LastName>Retel</LastName>

						<AffiliationInfo>
						<Affiliation>Division of
Psychosocial Research and Epidemiology, The Netherlands Cancer InstituteAntoni van Leeuwenhoek, Amsterdam, The Netherlands</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Department of Health
Technology and Services Research, University of Twente, Enschede, The
Netherlands</Affiliation>
						</AffiliationInfo>

</Author>
<Author>
					<FirstName>Janneke P.C.</FirstName>
					<LastName>Grutters</LastName>

						<AffiliationInfo>
						<Affiliation>Department of Operating Rooms, Radboud Institute for Health Sciences,
Radboud University Medical Center, Nijmegen, The Netherlands</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Department for Health Evidence, Radboud Institute for Health
Sciences, Radboud University Medical Center, Nijmegen, The Netherlands</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0002-2579-1561</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>01</Month>
					<Day>06</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span class=&quot;fontstyle0&quot;&gt;Background&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;Over the past decade, many hospitals have adopted hybrid operating rooms (ORs). As resources are limited, these ORs have to prove themselves in adding value. Current estimations on standard OR costs show great variety, while cost analyses of hybrid ORs are lacking. Therefore, this study aims to identify the cost drivers of a conventional and hybrid OR and take a first step in evaluating the added value of the hybrid OR.&lt;/span&gt;&lt;br /&gt; &lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Methods&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;A comprehensive bottom-up cost analysis was conducted in five Dutch hospitals taking into account: construction, inventory, personnel and overhead costs by means of interviews and hospital specific data. The costs per minute for both ORs were calculated using the utilization rates of the ORs. Cost drivers were identified by sensitivity analyses.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Results&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;The costs per minute for the conventional OR and the hybrid OR were €9.45 (€8.60-€10.23) and €19.88 (€16.10-€23.07), respectively. Total personnel and total inventory costs had most impact on the conventional OR costs. For the hybrid OR the costs were mostly driven by utilization rate, total inventory and construction costs. The results were incorporated in an open access calculation model to enable adjustment of the input parameters to a specific hospital or country setting.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Conclusion&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;This study estimated a cost of €9.45 (€8.60-€10.23) and €19.88 (€16.10-€23.07) for the conventional and hybrid OR, respectively. The main factors influencing the OR costs are: total inventory costs, total construction costs, utilization rate, and total personnel costs. Our analysis can be used as a basis for future research focusing on evaluating value for money of this promising innovative OR. Furthermore, our results can inform surgeons, and decision and policy-makers in hospitals on the adoption and optimal utilization of new (hybrid) ORs.&lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Hybrid Operating Room</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Costs</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Surgery</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Bottom-Up</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3870_c255c05246a081654a0267cbb725f5a7.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Can Combining Performance-Based Financing With Equity Measures Result in Greater Equity in Utilization of Maternal Care Services? Evidence From Burkina Faso</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>308</FirstPage>
			<LastPage>322</LastPage>
			<ELocationID EIdType="pii">3873</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.121</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Takondwa</FirstName>
					<LastName>Mwase</LastName>
<Affiliation>Heidelberg Institute of Global Health, Medical Faculty and University Hospital,
Heidelberg University, Heidelberg, Germany</Affiliation>
<Identifier Source="ORCID">0000-0002-3067-3981</Identifier>

</Author>
<Author>
					<FirstName>Julia</FirstName>
					<LastName>Lohmann</LastName>

						<AffiliationInfo>
						<Affiliation>Heidelberg Institute of Global Health, Medical Faculty and University Hospital,
Heidelberg University, Heidelberg, Germany</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Department of Global Health
and Development, London School of Hygiene &amp; Tropical Medicine, London,
UK</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0003-4136-9296</Identifier>

</Author>
<Author>
					<FirstName>Saidou</FirstName>
					<LastName>Hamadou</LastName>
<Affiliation>The World Bank, Yaoundé, Cameroon</Affiliation>
<Identifier Source="ORCID">0000-0002-0650-7473</Identifier>

</Author>
<Author>
					<FirstName>Stephan</FirstName>
					<LastName>Brenner</LastName>
<Affiliation>Heidelberg Institute of Global Health, Medical Faculty and University Hospital,
Heidelberg University, Heidelberg, Germany</Affiliation>
<Identifier Source="ORCID">0000-0001-5397-7008</Identifier>

</Author>
<Author>
					<FirstName>Serge M.A.</FirstName>
					<LastName>Somda</LastName>

						<AffiliationInfo>
						<Affiliation>Centre MURAZ, Bobo-Dioulasso,
Burkina Faso</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>UFR/ST, Université Nazi Boni, Bobo-Dioulasso, Burkina Faso</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0001-9855-9395</Identifier>

</Author>
<Author>
					<FirstName>Hervé</FirstName>
					<LastName>Hien</LastName>
<Affiliation>Centre MURAZ, Bobo-Dioulasso,
Burkina Faso</Affiliation>
<Identifier Source="ORCID">0000-0003-2578-7535</Identifier>

</Author>
<Author>
					<FirstName>Michael</FirstName>
					<LastName>Hillebrecht</LastName>
<Affiliation>Heidelberg Institute of Global Health, Medical Faculty and University Hospital,
Heidelberg University, Heidelberg, Germany</Affiliation>
<Identifier Source="ORCID">0000-0003-1799-952X</Identifier>

</Author>
<Author>
					<FirstName>Manuela</FirstName>
					<LastName>De Allegri</LastName>
<Affiliation>Heidelberg Institute of Global Health, Medical Faculty and University Hospital,
Heidelberg University, Heidelberg, Germany</Affiliation>
<Identifier Source="ORCID">0000-0002-8677-1337</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>09</Month>
					<Day>12</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span class=&quot;fontstyle0&quot;&gt;Background&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;As countries reform health financing systems towards universal health coverage, increasing concerns emerge on the need to ensure inclusion of the most vulnerable segments of society, working to counteract existing inequities in service coverage. To this end, selected countries in sub-Saharan Africa have decided to couple performance-based financing (PBF) with demand-side equity measures. Still, evidence on the equity impacts of these more complex PBF models is largely lacking. We aimed at filling this gap in knowledge by assessing the equity impact of PBF combined with equity measures on utilization of maternal health services in Burkina Faso.&lt;br /&gt;&lt;/span&gt; &lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Methods&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;Our study took place in 24 districts in rural Burkina Faso. We implemented an experimental design (cluster-randomized trial) nested within a quasi-experimental one (pre- and post-test design with independent controls). Our analysis relied on self-reported data on pregnancy history from 9999 (baseline) and 11 010 (endline) women of reproductive age (15-49 years) on use of maternal healthcare and reproductive health services, and estimated effects using a difference-in-differences (DID) approach, purposely focused on identifying program effects among the poorest wealth quintile.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Results&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;PBF improved the utilization of few selected maternal health services compared to status quo service provision. These benefits, however, were not accrued by the poorest 20%, but rather by the other quintiles. PBF combined with equity measures did not produce better or more equitable results than standard PBF, with specific differences only on selected outcomes.&lt;br /&gt;&lt;/span&gt; &lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Conclusion&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;Our findings challenge the notion that implementing equity measures alongside PBF is sufficient to produce an equitable distribution in program benefits and point at the need to identify more innovative and context-sensitive measures to ensure adequate access to care for the poorest. Our findings also highlight the importance of considering changing policy environments and the need to assess interferences across policies.&lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Performance-Based Financing</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Equity</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Equity Measures</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Maternal Health Services</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Burkina Faso</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3873_db346ccb62d491029b590bbbf0f5c412.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>“Not Just a Journal Club – It’s Where the Magic Happens”: Knowledge Mobilization through Co-Production for Health System Development in the Western Cape Province, South Africa</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>323</FirstPage>
			<LastPage>333</LastPage>
			<ELocationID EIdType="pii">3874</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.128</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>The Western Cape HPSR</FirstName>
					<LastName>Journal Club Team</LastName>
<Affiliation>A list of The Western
Cape HPSR Journal Club
Team is provided in the
Acknowledgments.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>01</Month>
					<Day>24</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span class=&quot;fontstyle0&quot;&gt;Background&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;The field of Health Policy and Systems Research (HPSR) views researchers as active participants in processes of knowledge mobilization, learning and action. Yet few studies examine how such processes are institutionalized or consider their health system or wider impacts. This paper aims to contribute insights by presenting a South African experience: the Western Cape (WC) HPSR Journal Club (JC).&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Methods&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;The paper draws on collective reflection by its authorial team, who are managerial and academic JC participants; reflective discussions with a wider range of people; and external evaluation reports. The analysis has been validated through rounds of collective engagement among authors, and through comparison with the wider sets of data, documentation and international literature. It considers impacts using a framework drawn from the co-production literature.&lt;/span&gt;&lt;br /&gt; &lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Results&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;Since 2012, the JC has brought together provincial and local government health system managers and academics to discuss complex systems’ and social science perspectives on health system development. The JC impacts encompass the trusting relationships (group micro-level) that have not only strengthened personal confidence and leadership skills (individual micro level), but also led to organizational impacts (meso level), such as practice and policy changes (practitioner organizations) and strengthened research and post-graduate teaching programs (academic organizations). Macro-societal impacts are, finally, judged likely to have resulted from new health system practices and policies and from academic post-graduate training activities. This set of impacts has been enabled by: the context of the JC; aspects of the JC design that underpin trusting relationships and mutual learning; the sustained participation of senior health system managers and academic managers who are able to translate new ideas into practice in their own organizational environments; and our individual and collective motivations – including the shared goal of health system development for social justice. Our challenges include risks and costs to ourselves, and the potential exclusion of challenging voices.&lt;/span&gt;&lt;br /&gt; &lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Conclusion&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;The principles and practice of the JC approach, rather than the JC as a model, offer ideas for others wishing to mobilize knowledge for health system development through embedded and co production processes. It demonstrates the potential for productive human interactions to seed long lasting systemic change.&lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Embedded Research</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Co-production</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Knowledge Mobilisation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">South Africa</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3874_2ed80f6311c1825feb854d78fa969d34.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Estimating COVID-19-Related Infections, Deaths, and Hospitalizations in Iran Under Different Physical Distancing and Isolation Scenarios</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>334</FirstPage>
			<LastPage>343</LastPage>
			<ELocationID EIdType="pii">3876</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.134</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Hamid</FirstName>
					<LastName>Sharifi</LastName>

						<AffiliationInfo>
						<Affiliation>HIV/STI Surveillance Research Center, and WHO Collaborating Center for
HIV Surveillance, Institute for Futures Studies in Health, Kerman University of
Medical Sciences, Kerman, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Department of Biostatistics and Epidemiology,
School of Public Health, Kerman University of Medical Sciences, Kerman, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0002-9008-7618</Identifier>

</Author>
<Author>
					<FirstName>Yunes</FirstName>
					<LastName>Jahani</LastName>

						<AffiliationInfo>
						<Affiliation>Modeling in Health Research Center, Institute for Futures Studies in Health,
Kerman University of Medical Sciences, Kerman, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Department of Biostatistics and Epidemiology,
School of Public Health, Kerman University of Medical Sciences, Kerman, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0002-6808-7101</Identifier>

</Author>
<Author>
					<FirstName>Ali</FirstName>
					<LastName>Mirzazadeh</LastName>

						<AffiliationInfo>
						<Affiliation>Department of
Epidemiology and Biostatistics, Institute for Global Health Sciences, University
of California San Francisco, San Francisco, CA, USA</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>HIV/STI Surveillance Research Center, and WHO Collaborating Center for
HIV Surveillance, Institute for Futures Studies in Health, Kerman University of
Medical Sciences, Kerman, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0002-0478-3220</Identifier>

</Author>
<Author>
					<FirstName>Milad</FirstName>
					<LastName>Ahmadi Gohari</LastName>
<Affiliation>Modeling in Health Research Center, Institute for Futures Studies in Health,
Kerman University of Medical Sciences, Kerman, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-1998-9157</Identifier>

</Author>
<Author>
					<FirstName>Mehran</FirstName>
					<LastName>Nakhaeizadeh</LastName>

						<AffiliationInfo>
						<Affiliation>Modeling in Health Research Center, Institute for Futures Studies in Health,
Kerman University of Medical Sciences, Kerman, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Department of Biostatistics and Epidemiology,
School of Public Health, Kerman University of Medical Sciences, Kerman, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0001-8441-6975</Identifier>

</Author>
<Author>
					<FirstName>Mostafa</FirstName>
					<LastName>Shokoohi</LastName>

						<AffiliationInfo>
						<Affiliation>HIV/STI Surveillance Research Center, and WHO Collaborating Center for
HIV Surveillance, Institute for Futures Studies in Health, Kerman University of
Medical Sciences, Kerman, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Dalla Lana School
of Public Health, University of Toronto, Toronto, ON, Canada</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0002-3810-752X</Identifier>

</Author>
<Author>
					<FirstName>Sana</FirstName>
					<LastName>Eybpoosh</LastName>
<Affiliation>Department
of Epidemiology and Biostatistics, Research Centre for Emerging and
Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-2304-8352</Identifier>

</Author>
<Author>
					<FirstName>Hamid Reza</FirstName>
					<LastName>Tohidinik</LastName>

						<AffiliationInfo>
						<Affiliation>HIV/STI Surveillance Research Center, and WHO Collaborating Center for
HIV Surveillance, Institute for Futures Studies in Health, Kerman University of
Medical Sciences, Kerman, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Department of Biostatistics and Epidemiology,
School of Public Health, Kerman University of Medical Sciences, Kerman, Iran</Affiliation>
						</AffiliationInfo>

</Author>
<Author>
					<FirstName>Ehsan</FirstName>
					<LastName>Mostafavi</LastName>
<Affiliation>Department
of Epidemiology and Biostatistics, Research Centre for Emerging and
Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-1997-517X</Identifier>

</Author>
<Author>
					<FirstName>Davood</FirstName>
					<LastName>Khalili</LastName>
<Affiliation>Prevention of Metabolic Disorders Research Center, Research Institute
for Endocrine Sciences, Shahid Beheshti University of Medical Sciences,
Tehran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-4956-1039</Identifier>

</Author>
<Author>
					<FirstName>Seyed Saeed</FirstName>
					<LastName>Hashemi Nazari</LastName>
<Affiliation>Prevention of Cardiovascular Disease Research Center,
Department of Epidemiology, School of Public Health and Safety, Shahid
Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad</FirstName>
					<LastName>Karamouzian</LastName>

						<AffiliationInfo>
						<Affiliation>HIV/STI Surveillance Research Center, and WHO Collaborating Center for
HIV Surveillance, Institute for Futures Studies in Health, Kerman University of
Medical Sciences, Kerman, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>School of Population
and Public Health, Faculty of Medicine, University of British Columbia,
Vancouver, BC, Canada</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0002-5631-4469</Identifier>

</Author>
<Author>
					<FirstName>Ali Akbar</FirstName>
					<LastName>Haghdoost</LastName>

						<AffiliationInfo>
						<Affiliation>Modeling in Health Research Center, Institute for Futures Studies in Health,
Kerman University of Medical Sciences, Kerman, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>HIV/STI Surveillance Research Center, and WHO Collaborating Center for
HIV Surveillance, Institute for Futures Studies in Health, Kerman University of
Medical Sciences, Kerman, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0003-4628-4849</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>05</Month>
					<Day>07</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span class=&quot;fontstyle0&quot;&gt;Background&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;Iran is one of the first few countries that was hit hard with the coronavirus disease 2019 (COVID-19) pandemic. We aimed to estimate the total number of COVID-19 related infections, deaths, and hospitalizations in Iran under different physical distancing and isolation scenarios.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Methods&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;We developed a susceptible-exposed-infected/infectious-recovered/removed (SEIR) model, parameterized to the COVID-19 pandemic in Iran. We used the model to quantify the magnitude of the outbreak in Iran and assess the effectiveness of isolation and physical distancing under five different scenarios (A: 0% isolation, through E: 40% isolation of all infected cases). We used Monte-Carlo simulation to calculate the 95% uncertainty intervals (UIs).&lt;br /&gt;&lt;/span&gt; &lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Results&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;Under scenario A, we estimated 5 196 000 (UI 1 753 000-10 220 000) infections to happen till mid-June with 966 000 (UI 467 800-1 702 000) hospitalizations and 111 000 (UI 53 400-200 000) deaths. Successful implantation of scenario E would reduce the number of infections by 90% (ie, 550 000) and change the epidemic peak from 66 000 on June 9, to 9400 on March 1, 2020. Scenario E also reduces the hospitalizations by 92% (ie, 74 500), and deaths by 93% (ie, 7800).&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Conclusion&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;With no approved vaccination or therapy available, we found physical distancing and isolation that include public awareness and case-finding and isolation of 40% of infected people could reduce the burden of COVID-19 in Iran by 90% by mid-June.&lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">COVID-19</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Modeling</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Physical Distancing</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Isolation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Iran</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3876_834a3bd235bca0caa53141f2ebc30438.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Views on Workplace Policies and its Impact on Health-Related Quality of Life During Coronavirus Disease (COVID-19) Pandemic: Cross-Sectional Survey of Employees</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>344</FirstPage>
			<LastPage>353</LastPage>
			<ELocationID EIdType="pii">3879</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.127</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Eliza Lai-Yi</FirstName>
					<LastName>Wong</LastName>
<Affiliation>JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China</Affiliation>
<Identifier Source="ORCID">0000-0001-9983-6219</Identifier>

</Author>
<Author>
					<FirstName>Kai-Fai</FirstName>
					<LastName>Ho</LastName>
<Affiliation>JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China</Affiliation>
<Identifier Source="ORCID">0000-0001-7464-3437</Identifier>

</Author>
<Author>
					<FirstName>Samuel Yeung-Shan</FirstName>
					<LastName>Wong</LastName>
<Affiliation>JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China</Affiliation>
<Identifier Source="ORCID">0000-0003-0934-6385</Identifier>

</Author>
<Author>
					<FirstName>Annie Wai-Ling</FirstName>
					<LastName>Cheung</LastName>
<Affiliation>JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China</Affiliation>
<Identifier Source="ORCID">0000-0001-6968-6221</Identifier>

</Author>
<Author>
					<FirstName>Peter Sen-Yung</FirstName>
					<LastName>Yau</LastName>
<Affiliation>JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China</Affiliation>

</Author>
<Author>
					<FirstName>Dong</FirstName>
					<LastName>Dong</LastName>
<Affiliation>JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China</Affiliation>
<Identifier Source="ORCID">0000-0001-9784-6472</Identifier>

</Author>
<Author>
					<FirstName>Eng-Kiong</FirstName>
					<LastName>Yeoh</LastName>
<Affiliation>JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China</Affiliation>
<Identifier Source="ORCID">0000-0002-1721-9450</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>05</Month>
					<Day>18</Day>
				</PubDate>
			</History>
		<Abstract>Background&lt;br /&gt;This study explored the degree of views towards supportive workplace policies among employees during coronavirus disease 2019 (COVID-19) pandemic and its association with health-related quality of life (HRQoL) in Hong Kong.&lt;br /&gt; &lt;br /&gt;Methods&lt;br /&gt;A cross-sectional study was conducted in 1049 employees using online self-administered questionnaire. Views on workplace policies were measured in term of agreement on its comprehensiveness, timeliness and transparency whereas HRQoL was measured using EQ-5D-5L Hong Kong version. Univariate estimates on the impact of HRQoL from views of measures in workplace was done. Qualitative comments on the suggestions to strengthen workplace measures were collected and presented descriptively.&lt;br /&gt; &lt;br /&gt;Results&lt;br /&gt;Of 1048 respondents, 16% reported that no workplace measures nor guidelines were existed in their company related to the COVID-19 pandemics. Those who reported having workplace policy were not satisfied with the arrangement in term of comprehensiveness (36%), timeliness (38%), and transparency (63%). Regarding to the policy measure, only 68% respondents reported that their workplace supplied face masks to them. The health index was 0897, which was lower than the norm of 0.924. 64% of respondents reported having a health problem in at least 1 of 5 dimension of EQ-5D-5L with the highest proportion of having problem in anxiety/depression (55%). In addition, the workplace policy and measure had a direct effect of 0.131 on health outcome. Perception of infection risk had a direct effect of 0.218 on health outcome and partly mediated the relationship between workplace policy and measure and health outcome (0.066).&lt;br /&gt; &lt;br /&gt;Conclusion&lt;br /&gt;The study highlighted the workplace policy and measure is an important mean to minimize infection risk at workplace so as to reduce tremendous stress and health outcome caused by a COVID-19 pandemic. Workplace measures related to COVID-19 pandemic should be further strengthen to mitigate the risk of infection and protect employee’s health.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Workplace Policies</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Health-Related Quality of Health</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Occupational Health</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Employees</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">COVID-19</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hong Kong</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3879_cc58f7abf0b0cf2d5ac95ab60e4f14e9.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Why Do They Leave? Challenges to Retention of Surgical Clinical Officers in District Hospitals in Malawi</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>354</FirstPage>
			<LastPage>361</LastPage>
			<ELocationID EIdType="pii">3882</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.142</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Jakub</FirstName>
					<LastName>Gajewski</LastName>
<Affiliation>Institute of Global Surgery, Royal College of Surgeons in Ireland, Dublin 2,
Ireland</Affiliation>
<Identifier Source="ORCID">0000-0003-0440-6051</Identifier>

</Author>
<Author>
					<FirstName>Marisa</FirstName>
					<LastName>Wallace</LastName>
<Affiliation>Faculty of Health, Medicine and Life Science, Maastricht University,
Maastricht, The Netherlands</Affiliation>

</Author>
<Author>
					<FirstName>Chiara</FirstName>
					<LastName>Pittalis</LastName>
<Affiliation>Division of Population Health Sciences, Royal
College of Surgeons in Ireland, Dublin 2, Ireland</Affiliation>
<Identifier Source="ORCID">0000-0003-3465-9850</Identifier>

</Author>
<Author>
					<FirstName>Gerald</FirstName>
					<LastName>Mwapasa</LastName>
<Affiliation>Department of Surgery,
College of Medicine Malawi, Blantyre, Malawi</Affiliation>

</Author>
<Author>
					<FirstName>Eric</FirstName>
					<LastName>Borgstein</LastName>
<Affiliation>Department of Surgery,
College of Medicine Malawi, Blantyre, Malawi</Affiliation>

</Author>
<Author>
					<FirstName>Leon</FirstName>
					<LastName>Bijlmakers</LastName>
<Affiliation>Radboud University Medical
Centre, Nijmegen, The Netherlands</Affiliation>
<Identifier Source="ORCID">0000-0003-2252-0579</Identifier>

</Author>
<Author>
					<FirstName>Ruairi</FirstName>
					<LastName>Brugha</LastName>
<Affiliation>Division of Population Health Sciences, Royal
College of Surgeons in Ireland, Dublin 2, Ireland</Affiliation>
<Identifier Source="ORCID">0000-0003-0729-0197</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>02</Month>
					<Day>04</Day>
				</PubDate>
			</History>
		<Abstract>Background&lt;br /&gt;Low- and middle-income countries (LMICs) are the worst affected by a lack of safe and affordable access to safe surgery. The significant unmet surgical need can be in part attributed to surgical workforce shortages that disproportionately affect rural areas of these countries. To combat this, Malawi has introduced a cadre of non-physician clinicians (NPCs) called clinical officers (COs), trained to the level of a Bachelor of Science (BSc) in Surgery. This study explored the barriers and enablers to their retention in rural district hospitals (DHs), as perceived by the first cohort of COs trained to BSc in Surgery level in Malawi.&lt;br /&gt; &lt;br /&gt;Methods&lt;br /&gt;A longitudinal qualitative research approach was used based on interviews with 16 COs, practicing at DHs, during their BSc training (2015); and again with 15 of them after their graduation (2019). Data from both time points were analysed and compared using a top-down thematic analysis approach.&lt;br /&gt; &lt;br /&gt;Results&lt;br /&gt;Of the 16 COs interviewed in 2015, 11 intended to take up a post at a DH following graduation; however, only 6 subsequently did so. The major barriers to remaining in a DH post as perceived by these COs were lack of promotion, a more attractive salary elsewhere; and unclear, stagnant career progression within surgery. For those who remained working in DH posts, the main enablers are a willingness to accept a low salary, to generate greater opportunities to engage in additional earning opportunities; the hope of promotional opportunities within the government system; and greater responsibility and recognition of their surgical knowledge and skills as a BSc-holder at the district level.&lt;br /&gt; &lt;br /&gt;Conclusion&lt;br /&gt;The sustainability of surgically trained NPCs in Malawi is not assured and further work is required to develop and implement successful retention strategies, which will require a multi-sector approach. This paper provides insights into barriers and enablers to retention of this newly-introduced cadre and has important lessons for policy-makers in Malawi and other countries employing NPCs to deliver essential surgery.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Non-physician Clinicians</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Task-Sharing</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Global Surgery</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Malawi</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3882_df42e2244c97a0d80d565ae8176d3351.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Measuring Governance: Developing a Novel Metric for Assessing Whether Policy Environments are Conducive for the Development and Implementation of Nutrition Interventions in Nepal</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>362</FirstPage>
			<LastPage>373</LastPage>
			<ELocationID EIdType="pii">3883</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.135</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Grace</FirstName>
					<LastName>Namirembe</LastName>
<Affiliation>Friedman School of Nutrition Science and Policy, Tufts University, Boston MA,
USA</Affiliation>
<Identifier Source="ORCID">0000-0002-8017-4144</Identifier>

</Author>
<Author>
					<FirstName>Robin</FirstName>
					<LastName>Shrestha</LastName>
<Affiliation>Friedman School of Nutrition Science and Policy, Tufts University, Boston MA,
USA</Affiliation>
<Identifier Source="ORCID">0000-0001-9729-2123</Identifier>

</Author>
<Author>
					<FirstName>Patrick</FirstName>
					<LastName>Webb</LastName>
<Affiliation>Friedman School of Nutrition Science and Policy, Tufts University, Boston MA,
USA</Affiliation>
<Identifier Source="ORCID">0000-0002-9857-3354</Identifier>

</Author>
<Author>
					<FirstName>Robert</FirstName>
					<LastName>Houser</LastName>
<Affiliation>Friedman School of Nutrition Science and Policy, Tufts University, Boston MA,
USA</Affiliation>
<Identifier Source="ORCID">0000-0002-8645-5561</Identifier>

</Author>
<Author>
					<FirstName>Dale</FirstName>
					<LastName>Davis</LastName>
<Affiliation>Department of Community Health Sciences, Patan Academy of Health
Sciences, Lalitpur, Nepal</Affiliation>

</Author>
<Author>
					<FirstName>Kedar</FirstName>
					<LastName>Baral</LastName>
<Affiliation>Helen Keller International, Patan, Nepal</Affiliation>
<Identifier Source="ORCID">0000-0002-3689-2763</Identifier>

</Author>
<Author>
					<FirstName>Julieta</FirstName>
					<LastName>Mezzano</LastName>
<Affiliation>Friedman School of Nutrition Science and Policy, Tufts University, Boston MA,
USA</Affiliation>
<Identifier Source="ORCID">0000-0001-6029-5785</Identifier>

</Author>
<Author>
					<FirstName>Shibani</FirstName>
					<LastName>Ghosh</LastName>
<Affiliation>Friedman School of Nutrition Science and Policy, Tufts University, Boston MA,
USA</Affiliation>
<Identifier Source="ORCID">0000-0001-5893-6774</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2019</Year>
					<Month>11</Month>
					<Day>13</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span class=&quot;fontstyle0&quot;&gt;Background&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;The Nutrition Governance Index (NGI) defines a first standardized approach to quantifying the ‘quality of governance’ in relation to national plans of action to accelerate improvements in nutrition. It was created in response to growing demand for evidence-based measures that reveal opportunities and challenges as nutrition-related policies on paper are translated into outcomes on the ground. Numerous past efforts to measure ‘governance,’ most notably World Health Organization’s (WHO’s) NGI and the separate Hunger and Nutrition Commitment Index (HANCI), both of which lack granularity below the national level and each of which fails to capture pinch points related to necessary crosssectoral actions. This paper addresses such caveats by introducing an innovative metric to assess self-reported practices of, and perceptions held by, administration officials tasked with implementing government policy at the sub-national level. The paper discusses the development of this metric, its methodology, and explores its application in the context of Nepal.&lt;/span&gt;&lt;br /&gt; &lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Methods&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;Conducted as part of a nationally representative longitudinal survey across 21 of Nepal’s 75 districts, the substudy on which this paper is based used data from 520 government and non government officials at different geographic and administrative tiers of authority. Using robust statistical techniques, structured questionnaire data were condensed into a score using a scale from 0 to 100.&lt;/span&gt;&lt;br /&gt; &lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Results&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;Six domains were identified through the analysis: Understanding Nutrition and related responsibilities; Collaboration; Financial Resources; Nutrition Leadership, Capacity, and Support. About half of all health sector representatives achieved a high score (&gt;3 on 5-point scale) compared to representatives in other sectors of government activity (such as agriculture or education) (χ&lt;/span&gt;&lt;span class=&quot;fontstyle2&quot;&gt;2&lt;/span&gt;&lt;span class=&quot;fontstyle2&quot;&gt;= 12.99, &lt;/span&gt;&lt;span class=&quot;fontstyle3&quot;&gt;P &lt;/span&gt;&lt;span class=&quot;fontstyle2&quot;&gt;&lt; .003). The health sector also showed the most improvement in mean NGI score over a two-year follow-up period.&lt;br /&gt;&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle0&quot;&gt;Conclusion&lt;/span&gt;&lt;br /&gt;&lt;span class=&quot;fontstyle2&quot;&gt;This paper shows that self-reported perceptions and behaviors of those responsible for policy implementation can be usefully quantified. The NGI can be used to assess countries’ readiness for the application of nutrition policies.&lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Nutrition Governance</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Policy Environments</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">metrics</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Malnutrition</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Nepal</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3883_51f3eb940fd73a19119534c063967bff.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Ethical and Social Values for Paediatric Health Technology Assessment and Drug Policy</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>374</FirstPage>
			<LastPage>382</LastPage>
			<ELocationID EIdType="pii">3889</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.144</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Avram E.</FirstName>
					<LastName>Denburg</LastName>

						<AffiliationInfo>
						<Affiliation>Division of Haematology/Oncology, Department of Paediatrics, The Hospital
for Sick Children, Toronto, ON, Canada</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Child Health Evaluative Sciences,
Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children,
Toronto, ON, Canada</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Institute of Health Policy, Management and Evaluation,
University of Toronto, Toronto, ON, Canada</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0003-0039-0742</Identifier>

</Author>
<Author>
					<FirstName>Mita</FirstName>
					<LastName>Giacomini</LastName>
<Affiliation>Department of Health Research
Methods, Evidence and Impact, Centre for Health Economics and Policy
Analysis, McMaster University, Hamilton, ON, Canada</Affiliation>

</Author>
<Author>
					<FirstName>Wendy</FirstName>
					<LastName>Ungar</LastName>

						<AffiliationInfo>
						<Affiliation>Child Health Evaluative Sciences,
Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children,
Toronto, ON, Canada</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Institute of Health Policy, Management and Evaluation,
University of Toronto, Toronto, ON, Canada</Affiliation>
						</AffiliationInfo>

</Author>
<Author>
					<FirstName>Julia</FirstName>
					<LastName>Abelson</LastName>
<Affiliation>Department of Health Research
Methods, Evidence and Impact, Centre for Health Economics and Policy
Analysis, McMaster University, Hamilton, ON, Canada</Affiliation>
<Identifier Source="ORCID">0000-0002-2907-2783</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>03</Month>
					<Day>23</Day>
				</PubDate>
			</History>
		<Abstract>Background&lt;br /&gt;Public policy approaches to funding paediatric medicines in advanced health systems remain understudied. In particular, the ethical and social values dimensions of health technology assessment (HTA) and drug coverage decisions for children have received almost no attention in research or policy.&lt;br /&gt; &lt;br /&gt;Methods&lt;br /&gt;To elicit and understand the social values that influence decision-making for public funding of paediatric drugs, we undertook a series of in-depth, semi-structured interviews with a stratified purposive sample (n = 22) of stakeholders involved with or affected by drug funding decisions for children at the provincial (Ontario) and national levels in Canada. Constructivist grounded theory methodology guided data collection and thematic analysis.&lt;br /&gt; &lt;br /&gt;Results&lt;br /&gt;Our study provides empirical evidence about the unique ethical and social values dimensions of HTA for children, and describes a novel social values typology for paediatric drug policy decision-making. Three principal categories of values emerged from stakeholder reflections on HTA and drug policy-making for children: procedural values, structural values, and sociocultural values. Key findings include the importance of attention to the procedural legitimacy of HTA for children, with emphasis on the inclusion of child health voices in processes of technology appraisal and policy uptake; a role for HTA institutions to consider the equity impacts of technologies, both in setting review priorities and in assessing the value of technologies for public coverage; and the potential benefits of a distinct national framework to guide drug policy for children.&lt;br /&gt; &lt;br /&gt;Conclusion&lt;br /&gt;Current approaches to HTA are not well designed for the realities of child health and illness, nor the societal priorities regarding children that our study identified. This research generates new knowledge to inform decision-making on paediatric drugs by HTA institutions and government payers in Canada and other publicly-funded health systems, through insights into the relevant social values for child drug funding decisions from varied stakeholder groups.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Canada</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Children</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Health Technology Assessment</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Public Values</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Priority Setting</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Drug Coverage</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3889_86098ef82c97fa789a47a8d2e8800794.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Should Public Health and Policy Communities Interact With the Food Industry? It Depends on Context; Comment on “Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool”</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>383</FirstPage>
			<LastPage>385</LastPage>
			<ELocationID EIdType="pii">3913</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.176</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Katherine</FirstName>
					<LastName>Cullerton</LastName>
<Affiliation>School of Public Health, University of Queensland, Herston, QLD, Australia</Affiliation>
<Identifier Source="ORCID">0000-0001-9517-6380</Identifier>

</Author>
<Author>
					<FirstName>Jean</FirstName>
					<LastName>Adams</LastName>
<Affiliation>MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine,
Cambridge, UK</Affiliation>
<Identifier Source="ORCID">0000-0002-5733-7830</Identifier>

</Author>
<Author>
					<FirstName>Martin</FirstName>
					<LastName>White</LastName>
<Affiliation>MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine,
Cambridge, UK</Affiliation>
<Identifier Source="ORCID">0000-0002-1861-6757</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>08</Month>
					<Day>17</Day>
				</PubDate>
			</History>
		<Abstract>The issue of public health and policy communities engaging with food sector companies has long caused tension and debate. Ralston and colleagues’ article ‘Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool’ further examines this issue. They found widespread food industry opposition, not just to the details of the World Health Organization (WHO) tool, but to the very idea of it. In this commentary we reflect on this finding and the arguments for and against interacting with the food industry during different stages of the policy process. While involving the food industry in certain aspects of the policy process without favouring their business goals may seem like an intractable problem, we believe there are opportunities for progress that do not compromise our values as public health professionals. We suggest three key steps to making progress.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Nutrition</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Health Governance</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Conflict of Interest</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Food Industry</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Policy-Making</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3913_b085c4fa543afe32970749f5e2bcdc6a.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>WHO’s Attempt to Navigate Commercial Influence and Conflicts of Interest in Nutrition Programs While Engaging With Non-State Actors: Reflections on WHO Guidance for Nation States; Comment on “Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool”</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>386</FirstPage>
			<LastPage>390</LastPage>
			<ELocationID EIdType="pii">3914</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.162</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Marc A.</FirstName>
					<LastName>Rodwin</LastName>
<Affiliation>Law School, Suffolk University, Boston, MA, USA</Affiliation>
<Identifier Source="ORCID">0000-0002-0415-7131</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>08</Month>
					<Day>03</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span class=&quot;fontstyle0&quot;&gt;This commentary situates the comments submitted in response to the World Health Organization (WHO) draft guidance on conflicts of interest in national nutrition programs in light of: (1) WHO policies to protect WHO integrity; (2) the Framework of Engagement with Non-State Actors (FENSA); (3) WHO’s attempt to seek funds due to cuts in member contributions; and (4) attempts — often by corporate entities — to redefine conflicts of interest to avoid oversight of conflicts of interest and increase corporate influence. The WHO guidance defines conflicts of interest in ways that deviate from standard legal usage which confuses its analysis and facilitates the creation of conflicted public-private partnerships. The guidance suggests that nations can allow engagement with non-state actors when the benefits are greater than risks without separate check due to conflicts of interest. Instead, the WHO should have recommended that nations seek alternative ways to achieve their goals when non-state actors have significant institutional conflicts of interest.&lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Public Private Partnerships</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Ethics</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Corruption</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Influence</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3914_b85d65c39e12a5515c19fd72b6f48199.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Conflict of Interest in Nutrition: Where’s the Power?; Comment on “Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool”</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>391</FirstPage>
			<LastPage>393</LastPage>
			<ELocationID EIdType="pii">3919</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.177</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Jody</FirstName>
					<LastName>Harris</LastName>

						<AffiliationInfo>
						<Affiliation>Institute of Development Studies, University of Sussex, Brighton, UK</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>World
Vegetable Center, Bangkok, Thailand</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0002-3369-1253</Identifier>

</Author>
<Author>
					<FirstName>Nicholas</FirstName>
					<LastName>Nisbett</LastName>
<Affiliation>Institute of Development Studies, University of Sussex, Brighton, UK</Affiliation>

</Author>
<Author>
					<FirstName>Stuart</FirstName>
					<LastName>Gillespie</LastName>
<Affiliation>International Food Policy Research
Institute, Washington, DC, USA</Affiliation>
<Identifier Source="ORCID">0000-0002-8501-5943</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>07</Month>
					<Day>31</Day>
				</PubDate>
			</History>
		<Abstract>Actual or perceived conflict of interests (COIs) among public and private actors in the field of nutrition must be managed. Ralston et al expose sharply contrasting views on the new World Health Organization (WHO) COI management tool, highlighting the contested nature of global debates. Both the WHO COI tool and the Ralston et al paper are largely quiet on aspects of power among different actors, however, which we argue is integral to these conflicts. We suggest that power needs to be acknowledged as a factor in COI; that it needs to be systematically assessed in COI tools using approaches we outline here; and that it needs to be explicitly addressed through COI mechanisms. We would recommend that all actors in the nutrition space (not only private companies) are held to the same COI standards, and we would welcome further studies such as Ralston et al to further build accountability.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Power</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Conflict of Interest</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Nutrition</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Public Health</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Private Sector</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Accountability</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3919_5fc7c9bd1fcb12799f02da8adfa4954f.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>It Is Not Enough to Assess Conflicts of Interest When We Bring the Commercial Sector to the Policy Table; Comment on “Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool”</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>394</FirstPage>
			<LastPage>397</LastPage>
			<ELocationID EIdType="pii">4156</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2021.148</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Elisa</FirstName>
					<LastName>Chilet-Rosell</LastName>
<Affiliation>Department of Public Health, Universidad Miguel Hernández, Alicante, Spain</Affiliation>
<Identifier Source="ORCID">0000-0002-9091-7255</Identifier>

</Author>
<Author>
					<FirstName>Ildefonso</FirstName>
					<LastName>Hernandez-Aguado</LastName>

						<AffiliationInfo>
						<Affiliation>Department of Public Health, Universidad Miguel Hernández, Alicante, Spain</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0003-1911-5759</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2021</Year>
					<Month>08</Month>
					<Day>31</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span class=&quot;fontstyle0&quot;&gt;Ralston et al offer us an interesting analysis of the consultation process of World Health Organization’s (WHO’s) “Draft approach on the prevention and management of conflicts of interests in the policy development and implementation of nutrition programs at country level,” in which it shows us how the industry tries to frame the discussion in individual conflicts of interest, avoiding structural conflicts of interest. We must not forget other issues of importance in policymaking, such as the imbalance of power between different actors and the strategies of undue influence used by food and beverage corporations. It is essential to develop regulatory-based tools and procedures that embody ethics and good governance and that can be applied systematically and routinely to prevent corporate influence in health policymaking. A global observatory of corporate practices would also be needed to recommend to governments efficient actions to avoid corporate capture of their policies.&lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Conflict of Interest</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Undue Influences</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Governance</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Nutrition</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Policy-Making</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_4156_bba6bca05fecde04c682328e44b974b7.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Is It Possible to Solve the Conflicts Over Conflict of Interest?; Comment on “Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool”</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>398</FirstPage>
			<LastPage>400</LastPage>
			<ELocationID EIdType="pii">4185</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2021.178</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Stella Aguinaga</FirstName>
					<LastName>Bialous</LastName>
<Affiliation>Department of Social and Behavioural Sciences, School of Nursing, University of
California San Francisco, San Francisco, CA, USA</Affiliation>
<Identifier Source="ORCID">0000-0002-6471-5457</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2021</Year>
					<Month>07</Month>
					<Day>20</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span class=&quot;fontstyle0&quot;&gt;Addressing conflicts of interest (COIs) when developing and implementing policies to address commercial determinants of health is pivotal to ensure that these policies are free from commercial and other vested interests of unhealthy commodities industry. As a concept, this is well accepted within the tobacco control community, and supported by the existence of an international treaty, the WHO Framework Convention on Tobacco Control (FCTC). But in nutrition policy the engagement of the food industry appears to remain controversial, as efforts to create partnerships are still underway. There is a need to undertake evaluation of existing COI policies to assess their implementation and outcomes, creating best practice models that can be replicated, and understanding how to change norms within governments. Additionally, a review of existing norms, codes of conduct, and ethics to determine their impact on preventing COI would guide future implementation of these measures. Finally, governments, academics, and advocates should consider how existing tools, guidelines or other instruments could help frame the COI discussion to ensure its political feasibility. There is a need for a discussion on whether the current approach of separate policies for distinct industries is preferable than a broader COI policy that would be applicable to a wide range of unhealthy commodities and across governmental sectors.&lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Conflict of Interest</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Tobacco</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Food</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Commercial Determinants of Health</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Whole of Government</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_4185_b207f5c56605a9d1a22e1e134fe95ba9.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Advice for Food Systems Governance Actors to Decide Whether and How to Engage With the Agri-Food and Beverage Industry to Address Malnutrition Within the Context of Healthy and Sustainable Food Systems; Comment on “Challenges to Establish Effective Public-Private Partnerships to Address Malnutrition in All Its Forms”</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>401</FirstPage>
			<LastPage>406</LastPage>
			<ELocationID EIdType="pii">4074</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2021.70</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Vivica I.</FirstName>
					<LastName>Kraak</LastName>
<Affiliation>Department of Human Nutrition, Foods, and Exercise, College of Agriculture and Life Sciences, Virginia Polytechnic Institute and State University,
Blacksburg, VA, USA</Affiliation>
<Identifier Source="ORCID">0000-0002-9303-5530</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2021</Year>
					<Month>04</Month>
					<Day>18</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span class=&quot;fontstyle0&quot;&gt;The effectiveness of public-private partnerships (PPPs) to address malnutrition will depend on the issue, engagement purpose, policy context and actors’ interactions. This commentary offers advice for governments, United Nations (UN) and civil society organizations to decide whether and how to engage with industry actors to improve diets for populations. First, food systems governance actors must acknowledge and reconcile competing visions, harmonize numerous corporate-engagement principles, and support a shared narrative to motivate collective actions toward healthy sustainable diets. Second, food systems governance actors have tools to guide engagement through many alliances, networks, coalitions and multi-stakeholder platforms with different levels of risk and trust. Third, food systems governance actors must prioritize accountability by setting corporate-performance threshold scores to justify private-sector engagement; evaluating engagement processes, outcomes and consequences; using incentives, financial penalties and social media advocacy to accelerate time-bound changes; and revoking UN consultative status for corporate actors who undermine healthy people and planet.&lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Partnerships</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Engagement</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Malnutrition</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Healthy Diets</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Sustainable Food Systems</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Planetary Health</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_4074_0f9cafd014db7a619ddb4276af0d692c.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>11</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>How to Face COVID-19 Outbreak: Reconfiguration of a Private Radiological Clinic</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>407</FirstPage>
			<LastPage>408</LastPage>
			<ELocationID EIdType="pii">3903</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.2020.165</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Michaela</FirstName>
					<LastName>Cellina</LastName>
<Affiliation>Department of Radiology, ASST Fatebenefratelli Sacco, Milan, Italy</Affiliation>
<Identifier Source="ORCID">0000-0002-7401-1971</Identifier>

</Author>
<Author>
					<FirstName>Filippo</FirstName>
					<LastName>Pesapane</LastName>
<Affiliation>University
of Milan, Milan, Italy</Affiliation>
<Identifier Source="ORCID">0000-0002-0374-5054</Identifier>

</Author>
<Author>
					<FirstName>Laura</FirstName>
					<LastName>Bracchi</LastName>
<Affiliation>Cerba Healthcare Italia, Milan, Italy</Affiliation>

</Author>
<Author>
					<FirstName>Gianfranco</FirstName>
					<LastName>Bracchi</LastName>
<Affiliation>Cerba Healthcare Italia, Milan, Italy</Affiliation>

</Author>
<Author>
					<FirstName>Anna Maria</FirstName>
					<LastName>Ierardi</LastName>
<Affiliation>Radiology
Department, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico,
Milan, Italy</Affiliation>

</Author>
<Author>
					<FirstName>Carlo</FirstName>
					<LastName>Martinenghi</LastName>
<Affiliation>Cerba Healthcare Italia, Milan, Italy</Affiliation>

</Author>
<Author>
					<FirstName>Gianpaolo</FirstName>
					<LastName>Carrafiello</LastName>
<Affiliation>Radiology
Department, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico,
Milan, Italy</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>05</Month>
					<Day>12</Day>
				</PubDate>
			</History>
		<Abstract></Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Multidetector Computed Tomography</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">COVID-19</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Coronavirus 2</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Radiography</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Emergency Responders</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_3903_9d949c3d8baa0f9df6f22c4661946a61.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
